|
rdfs:label
|
"Dafagliflozin"@id
"Dapagliflozin"@de
"Dapagliflozin"@it
"Dapagliflozin"@sh
"Dapagliflozin"@sr
"Dapagliflozin"@tr
"Dapagliflozina"@es
"Dapagliflozină"@ro
"dapagliflotsiini"@fi
"dapagliflozin"@en
"dapagliflozin"@fr
"dapagliflozin"@nl
"dapagliflozin"@sl
"dapagliflozin"@gpe
"dapagliflozina"@ca
"dapagliflozina"@pt
"dapagliflozyna"@pl
"Δαπαγλιφλοζίνη"@el
"Дапаглифлозин"@mk
"Дапаглифлозин"@ru
"Дапагліфлозин"@uk
"דאפאגליפלוזין"@he
"داباغليفلوزين"@ar
"داپاگلیفلوزین"@fa
"ଡାପାଗ୍ଲିଫ୍ଲୋଜିନ "@or
"డాపాగ్లిఫ్లోజిన్"@te
"ダパグリフロジン"@ja
"达格列净"@zh
"达格列净"@zh-cn
"다파글리플로진"@ko
|
|
skos:altLabel
|
"(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol"@en
"(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol"@gpe
"BMS-512148"@mul
|
|
schema:description
|
"Arzneistoff"@de
"Kompozé chimik"@gcr
"SGLT2 억제제"@ko
"cheemesch Verbindung"@lb
"chemical compound"@en
"chemical compound"@en-ca
"chemical compound"@en-gb
"chemická sloučenina"@cs
"chemická zlúčenina"@sk
"chemiese verbinding"@af
"chemische Verbindung"@de-ch
"chemische verbinding"@nl
"component quimic"@oc
"composito chimic"@ia
"compositum chemicum"@la
"compost químic"@ca
"composto químico"@gl
"composto químico"@pt
"composto químico"@pt-br
"compuesto quimico"@an
"compuesto químico"@es
"compuestu químicu"@ast
"compus chimic"@ro
"conposto chìmego"@vec
"cumpostu chìmicu"@scn
"cyfansoddyn cemegol"@cy
"diabetes medication"@gpe
"farmaco"@it
"gemyske ferbining"@fy
"kediad kimiek"@br
"keemiline ühend"@et
"kemia kombinaĵo"@eo
"kemiala kompozajo"@io
"kemiallinen yhdiste"@fi
"kemisk forbindelse"@da
"kemična spojina"@sl
"kimyasal bileşik"@tr
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"komponim kimik"@sq
"konposatu kimiko"@eu
"médicament"@fr
"senyawa kimia"@id
"związek chemiczny"@pl
"ķīmisks savienojums"@lv
"χημική ένωση"@el
"хемиско соединение"@mk
"химическое соединение"@ru
"химично съединение"@bg
"хімічна сполука"@uk
"хімічнае злучэнне"@be
"хімічнае злучэньне"@be-tarask
"քիմիական միացություն"@hy
"תרכובת"@he
"مركب كيميائي"@ar
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
"ଡାପାଗ୍ଲିଫ୍ଲୋଜିନ ଏକ ଔଷଧ ଯାହା ଟାଇପ୍-୨ ମଧୁମେହର ଚିକିତ୍ସା ପାଇଁ ବ୍ୟବହୃତ ହୁଏ ।"@or
"രാസസംയുക്തം"@ml
"化合物"@yue
"化合物"@zh-hans
"化合物"@zh-hant
"化合物"@zh-hk
"化合物"@zh-sg
"化合物"@zh-tw
"化合物"@zh-mo
"化学合成物"@zh-cn
"化学合成物"@zh
|
|
schema:dateModified
|
"2026-11-07T14:26:58+00:00"^^xsd:dateTime
|
|
schema:version
|
2565934322
|
|
wikibase:identifiers
|
32
|
|
wikibase:sitelinks
|
28
|
|
wikibase:statements
|
53
|
|
p:P10245
|
wd:statement/Q409898-2df72513-4428-8a24-373d-4414dd81a4f1
|
|
p:P10283
|
wd:statement/Q409898-51E44A7E-2499-4B9A-BB67-6FA2E7507660
|
|
p:P11089
|
wd:statement/Q409898-9CECD60B-9F4A-4618-A3D0-2FEF3F6C18C4
|
|
p:P11143
|
wd:statement/Q409898-FA820C22-9D98-42A4-A080-A4E2692A7CF8
|
|
p:P11198
|
wd:statement/Q409898-D511704F-089E-4EF9-BF07-8F2852E73B12
|
|
p:P11199
|
wd:statement/Q409898-20A4FE01-6278-4988-91E2-C7EA7BF758E2
|
|
p:P117
|
wd:statement/Q409898-33f89814-4af9-fcb5-a3d8-4704aa45dd91
|
|
wd:statement/Q409898-476A62BC-84A3-4C11-AA0D-44B0BA3BEE0A
|
|
p:P129
|
wd:statement/Q409898-549BF84D-C467-4764-B97B-1CFD80E29199
|
|
wd:statement/Q409898-5F534632-7029-4200-82A0-DF4192AF57D8
|
|
p:P15001
|
wd:statement/Q409898-197404B7-5F21-4722-A478-562C1C889D15
|
|
p:P1579
|
wd:statement/Q409898-EF66E15A-2D51-4F56-86B3-8AEAB858B39B
|
|
p:P2017
|
wd:statement/Q409898-E69F8012-E402-4642-BFD9-D23CF7B3A3AC
|
|
p:P2067
|
wd:statement/Q409898-012C6FBF-ED80-4C7C-A125-351A04E616E7
|
|
p:P2115
|
wd:statement/Q409898-B9E08572-EAEA-44BD-935A-1DBE28363D4F
|
|
p:P2175
|
wd:statement/Q409898-99D49B1D-48A9-4E49-A4E1-F3B9202B335F
|
|
wd:statement/Q409898-B537BA94-896A-4D18-9FBF-D2D295DD3FD5
|
|
p:P227
|
wd:statement/Q409898-C6F9C399-596C-4B84-AC92-583F63ED65F7
|
|
p:P2275
|
wd:statement/Q409898-5EAF1C2E-C073-4602-B6DF-7A576661A44A
|
|
p:P231
|
wd:statement/Q409898-172BA67F-9D65-4B68-9C09-52E28B50F877
|
|
p:P232
|
wd:statement/Q409898-256E8322-A51B-4C51-8FF7-FAA2C963C146
|
|
p:P233
|
wd:statement/Q409898-EE18CABB-9158-4D97-886F-078D693D472D
|
|
p:P234
|
wd:statement/Q409898-0B5B90F2-263A-45ED-B60F-9A34F74C406D
|
|
p:P235
|
wd:statement/Q409898-31D2CDFB-B7C6-4BC2-8491-B5821BEEF57E
|
|
p:P2566
|
wd:statement/Q409898-13572468-2468-1357-eca9-bdf024681357
|
|
p:P267
|
wd:statement/Q409898-7C694EE5-C34F-4BA6-B68F-B88DC43DC6C1
|
|
p:P274
|
wd:statement/Q409898-8EDC3E0D-2446-40B4-9F5F-B29B6BDBF993
|
|
p:P279
|
wd:statement/Q409898-DCBA02A3-109B-4436-951A-92AB8D4D5F5A
|
|
p:P2868
|
wd:statement/Q409898-566EC543-3EB6-4F63-A5F8-170477755EF0
|
|
p:P2877
|
wd:statement/Q409898-EEF897C5-DAF8-4F4B-99DB-D026F9CDF893
|
|
p:P2892
|
wd:statement/Q409898-2068D0A4-005A-4942-822F-B243BC224E87
|
|
p:P31
|
wd:statement/Q409898-C3135636-E8EB-407D-9BA7-13BEDD023BBA
|
|
p:P3117
|
wd:statement/Q409898-8E74AA2D-DDF9-4BBB-AF76-86B7A9FF1AA9
|
|
p:P3345
|
wd:statement/Q409898-D6E463B6-B557-4F48-859B-C469725B66F3
|
|
p:P3489
|
wd:statement/Q409898-0E1D625F-8A76-4449-823C-2A8E9EC6DB98
|
|
p:P3636
|
wd:statement/Q409898-6DF5701B-AD85-4D4E-B506-88E04BF3DEA5
|
|
p:P366
|
wd:statement/Q409898-7AB780E5-E77D-45D9-96EA-D7BFF0E33CD3
|
|
p:P373
|
wd:statement/Q409898-72112e14-f7e6-43a8-b760-71903bb0f109
|
|
p:P3780
|
wd:statement/Q409898-75A88993-2DB2-4C83-98BD-159EA17EC891
|
|
p:P4250
|
wd:statement/Q409898-A6B8D633-5522-40B5-A50F-BB28CFE89662
|
|
p:P592
|
wd:statement/Q409898-1074F704-3FDC-4DA9-B178-848707D3547E
|
|
p:P595
|
wd:statement/Q409898-A73377D1-906F-4D9F-A8A4-3E5789BEFF14
|
|
p:P6366
|
wd:statement/Q409898-9C51D9DB-9958-4353-BD71-420DC6990708
|
|
p:P646
|
wd:statement/Q409898-867359F1-2FFA-455B-BEBA-E552740D4056
|
|
p:P652
|
wd:statement/Q409898-1EA05B03-B1C8-4E19-AF73-0D7F13FC00FC
|
|
p:P661
|
wd:statement/Q409898-D013F8D4-9536-42B6-8AEE-DB90D9CE483B
|
|
p:P662
|
wd:statement/Q409898-6CCBE07F-4762-40E6-8BD8-5986D05B8D20
|
|
p:P665
|
wd:statement/Q409898-227DD222-35D4-4630-B616-F2727BB00E90
|
|
p:P683
|
wd:statement/Q409898-AF477E26-CDE9-497F-9158-7835ADD200A8
|
|
p:P715
|
wd:statement/Q409898-E04DB715-6D6A-4D30-A007-B91252F36155
|
|
p:P8072
|
wd:statement/Q409898-E7A2A911-1161-4965-9EE7-274EBBAA43B4
|
|
p:P8494
|
wd:statement/Q409898-A6A90127-C781-46B9-9D84-95C78820C016
|
|
p:P856
|
wd:statement/Q409898-531AB90F-6669-4F12-95DD-117072157144
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000189942>
|
|
p:direct-normalized/P227
|
<https://d-nb.info/gnd/1350782106>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL429910>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2777422806>
|
|
p:direct-normalized/P661
|
<http://rdf.chemspider.com/8063384>
|
|
p:direct-normalized/P662
|
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9887712>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/D08897>
|
|
p:direct-normalized/P683
|
<http://purl.obolibrary.org/obo/CHEBI_85078>
|
|
wdt:P10245
|
"a614015"
|
|
wdt:P10283
|
"C2777422806"
|
|
wdt:P11089
|
"602231"
|
|
wdt:P11143
|
"Dapagliflozin"
|
|
wdt:P11198
|
"4304"
|
|
wdt:P11199
|
"PD000129"
|
|
wdt:P117
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Dapagliflozin%20structure.svg>
|
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Haworth%20projection%20of%20dapagliflozin.svg>
|
|
wdt:P129
|
Solute carrier family 5 member 2
|
|
Solute carrier family 5 member 1
|
|
wdt:P15001
|
"BMS-512148-05"
|
|
wdt:P1579
|
"11966426"
|
|
wdt:P2017
|
"CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl"
|
|
wdt:P2067
|
408.133966^^xsd:decimal
|
|
wdt:P2115
|
"N0000189942"
|
|
wdt:P2175
|
type-1 diabetes
|
|
type 2 diabetes
|
|
wdt:P227
|
"1350782106"
|
|
wdt:P2275
|
"dapagliflozin"@en
|
|
wdt:P231
|
"461432-26-8"
|
|
wdt:P232
|
"639-683-0"
|
|
wdt:P233
|
"CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl"
|
|
wdt:P234
|
"InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1"
|
|
wdt:P235
|
"JVHXJTBJCFBINQ-ADAARDCZSA-N"
|
|
wdt:P2566
|
"100.167.331"
|
|
wdt:P267
|
"A10BK01"
|
|
wdt:P274
|
"C₂₁H₂₅ClO₆"
|
|
wdt:P279
|
chemical compound
|
|
wdt:P2868
|
gliflozins
|
|
wdt:P2877
|
"157820"
|
|
wdt:P2892
|
"C2353951"
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3117
|
"DTXSID20905104"
|
|
wdt:P3345
|
"1488564"
|
|
wdt:P3489
|
US pregnancy category C
|
|
wdt:P3636
|
"LE6"
|
|
wdt:P366
|
medication
|
|
wdt:P373
|
"Dapagliflozin"
|
|
wdt:P3780
|
Farxiga
|
|
wdt:P4250
|
10.0^^xsd:decimal
|
|
wdt:P592
|
"CHEMBL429910"
|
|
wdt:P595
|
"4594"
|
|
wdt:P6366
|
"2777422806"
|
|
wdt:P646
|
"/m/02x9wcz"
|
|
wdt:P652
|
"1ULL0QJ8UC"
|
|
wdt:P661
|
"8063384"
|
|
wdt:P662
|
"9887712"
|
|
wdt:P665
|
"D08897"
|
|
wdt:P683
|
"85078"
|
|
wdt:P715
|
"DB06292"
|
|
wdt:P8072
|
"125835"
|
|
wdt:P8494
|
"DTXCID101334207"
|
|
wdt:P856
|
<https://www.farxiga.com>
|